Cargando…
The Long-Term Clinical Effectiveness of Ustekinumab in Antitumor Necrosis Factor-Experienced Crohn’s Disease Patients
Background Crohn’s disease (CD) is a chronic inflammatory bowel disease (IBD) of unknown etiology. Ustekinumab (UST), an interleukin (IL)-12 and IL-23 antibody, has been approved in the recent years to treat IBD, both Crohn’s disease and ulcerative colitis. This study clarifies the long-term effecti...
Autores principales: | Altuwaijri, Mansour, Hakami, Loai, Alharbi, Othman, Almadi, Majid, Alshankiti, Suliman, Aljebreen, Abdulrahman, Azzam, Nahla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514158/ https://www.ncbi.nlm.nih.gov/pubmed/36185868 http://dx.doi.org/10.7759/cureus.28536 |
Ejemplares similares
-
Rate and risk factors of postoperative endoscopic recurrence of moderate- to high-risk Crohn's disease patients - A real-world experience from a Middle Eastern cohort
por: Azzam, Nahla, et al.
Publicado: (2022) -
Clinical Epidemiology and Phenotypic Characteristics of Crohn's Disease in the Central Region of Saudi Arabia
por: Aljebreen, Abdulrahman M., et al.
Publicado: (2014) -
Clinical characteristics, natural history, and outcomes of Crohn's-related intra-abdominal collections
por: Alharbi, Othman, et al.
Publicado: (2021) -
Efficacy of Spyglass-Guided Electrohydraulic Lithotripsy in Difficult Bile Duct Stones
por: Aljebreen, Abdulrahman M., et al.
Publicado: (2014) -
Bowel preparation quality between hospitalized patients and outpatient colonoscopies
por: Almadi, Majid A., et al.
Publicado: (2018)